{"id":483871,"title":"Clinical Trial Application - Amendments (CTA-As) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T22:33:04.082000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/application-amendments.html?wbdisable=true","snippet":"Clinical Trial Application - Amendments (CTA-As) CTA-A s are applications in which a sponsor proposes information to support changes to a previously authorized application [ C.05.008 ]. Where a sponsor wishes to make changes to a CTA under review, the sponsor should withdraw the…","rawSnapshotUrl":"/api/snapshots/raw/483871","browseUrl":"https://replay.healtharchive.ca/job-6/20260106223304/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/application-amendments.html?wbdisable=true#ha_snapshot=483871","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}